For research use only, not for therapeutic use.
rac-Clopidogrel Hydrogen Sulfate (Cat No.:R028045) is a racemic mixture of clopidogrel hydrogen sulfate, an antiplatelet medication used to prevent blood clots and reduce the risk of cardiovascular events. It acts by irreversibly inhibiting a platelet receptor, preventing platelet aggregation and clot formation. This medication is prescribed to individuals with certain conditions at high risk of heart attacks and strokes. rac-Clopidogrel Hydrogen Sulfate contains both active and inactive enantiomers of clopidogrel, ensuring its therapeutic efficacy.
Catalog Number | R028045 |
CAS Number | 135046-48-9 |
Synonyms | (±)-Methyl 2-(2-Chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate Hydrogen Sulfate; (±)-Clopidogrel Bisulfate; Clopidogrel Hemisulfate; Iscover; Myogrel ; Plavix; SR 25990C; Stroka |
Molecular Formula | C₁₆H₁₈ClNO₆S₂ |
Purity | ≥95% |
Storage | 2-8°C |
IUPAC Name | methyl 2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid |
InChI | InChI=1S/C16H16ClNO2S.H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14;1-5(2,3)4/h2-5,7,9,15H,6,8,10H2,1H3;(H2,1,2,3,4) |
InChIKey | FDEODCTUSIWGLK-UHFFFAOYSA-N |
SMILES | COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O |